Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate

Novavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first participants, with preliminary results slated for July. Subscribe: http://smarturl.it/reuterssubscribe Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: http://reuters.com/ Follow Reuters on Facebook:   / reuters   Follow Reuters on Twitter:   / reuters   Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en